Refine my results
Document type
Institution
Specific Collection
Language
- English (3)
Author
- Aldridge, Julie (1)
- Bernhard, Jürg (1)
- Breitenstein, Urs (1)
- Cardoso, Fatima (1)
- Castiglione-Gertsch, M. (1)
- Coates, A. S. (1)
- Coates, Alan (1)
- Gelber, R. D. (1)
- Gelber, Richard (1)
- Goldhirsch, A. (1)
- Goldhirsch, Aron (1)
- Harvey, Vernon (1)
- Hiller, Christian (1)
- Jetter, Alexander (1)
- Kullak-Ublick, Gerd (1)
- Mwinyi, Jessica (1)
- Pagani, Olivia (1)
- Phillips, Kelly-Anne (1)
- Price, Karen (1)
- Ribi, Karin (1)
- Sun, Zhuoxin (1)
- Thompson, Alastair (1)
- Thürlimann, Beat (1)
- Trojan, Andreas (1)
- Vokinger, Kerstin (1) More Less
Keyword
- Tamoxifen (3)
- Breast cancer (2)
- 4-OH-tamoxifen : 4-Hydroxytamoxifen (1)
- AS : Activity score (1)
- Aromatase inhibitor (1)
- BC : Breast cancer (1)
- Cognitive function (1)
- Commentary (1)
- DFS : Disease-free survival (1)
- DM : Dextromethorphan (1)
- DX : Dextrorphan (1)
- Drug metabolism (1)
- EDTA : Ethylenediaminetetraacetic acid (1)
- EM : Extensive metabolizer (1)
- ER : Estrogen receptor (1)
- Genetic polymorphisms (1)
- HPLC : High pressure liquid chromatography (1)
- Herceptin™ (1)
- IM : Intermediate metabolizer (1)
- Letrozole (1)
- PCR : Polymerase chain reaction (1)
- PM : Poor metabolizer (1)
- PR : Progesterone receptor (1)
- Quality of life (1)
- RFT : Relapse-free time (1)
- Raloxifene (1)
- Relapse-free time (1)
- STD : Standard deviation (1)
- Therapy efficacy (1)
- UM : Ultrafast metabolizer (1) More Less